National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 10) (PB 103 of 2017) (Cth)

PB 103 of 2017

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 10)

National Health Act 1953

I, JULIANNE QUAINE, First Assistant Secretary (Acting), Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 13 December 2017

JULIANNE QUAINE

First Assistant Secretary (Acting)

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

Amendment instrument – Pharmaceutical benefits – early supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 10)

(2)This Instrument may also be cited as PB 103 of 2017.

2          Commencement

This Instrument commences on 1 January 2018.

3          Amendment of PB 120 of 2015

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1        Amendments

1. Schedule 1

omit:

Testosterone Transdermal solution (pump pack) 30 mg per 1.5 mL dose, 60 doses 20 1 5